Sexual Peptides

Clinically Structured Solutions for Sexual Function

Vuture delivers advanced peptide-based solutions designed to support sexual function through central nervous system pathways, within structured clinical use.
Our Therapeutic Category

Sexual Peptide Solutions

Formulations developed to support sexual desire and arousal through central signaling pathways, offering an alternative mechanism to traditional blood flow–based approaches.
Consectetur scelerisque lorem si praesent tortor aptent luctus congue vehicula curae bibendum. Vehicula nisi ac pulvinar ullamcorper proin consectetur.
PT-141 (Bremelanotide)

A centrally acting peptide used in clinical applications to support sexual desire and arousal.

Key Difference
Operates through brain signaling pathways, providing a different approach compared to conventional treatments that rely on vascular response.

CLINICAL APPLICATION

Female Use
Used in cases of reduced sexual desire, including Hypoactive Sexual Desire Disorder (HSDD), as part of structured clinical protocols.

Male Use
Used in cases of erectile dysfunction, particularly where traditional approaches may not provide consistent results.

Designed for Clinical Integration

Our solutions are developed to integrate into clinical workflows, allowing practitioners to apply structured approaches across sexual health protocols with consistency and control.

VUTURE

Precision

Consistency

Scale

This is Vuture
Advanced peptide-based solutions built for structured clinical use.
PARTNER WITH VUTURE

Build a More Reliable Clinical System

Access Advanced Clinical Solutions and a consistent Medical Supply system designed to support clinics with structured, scalable, and efficient operations.

Request Partnership Access

For clinics and healthcare Professionals